Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Dec 24, 2022 1:13pm

214 Views

Post# 35191134

You mean CEO Guy Averaged price down , Diluted shares

more shares for shareholders , you just keep buying all the way down to 0.00, tell us all how Tetra Bio Pharma will ever crawl out of the massive debt to to tune of $140,000,000 ,company is not worth 10,000,000 , payments coming due and loans at 15 % , brainless cheer leader , why are you averaging down if you made all this profit off the shares you bought at .13 cents earlier this year pumper ? 430,000,000 Tetra shares outstanding bonehead .

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects